News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 181–216
- Matches
- 1314
- Sources here
- 25
- Companies here
- 20
Active search
1314 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Academy Sports and Outdoors (ASO) Short Interest & Short Float | Updated Aug 2026
This article provides an updated overview of Academy Sports and Outdoors (ASO) short interest data as of July 31, 2026. It details that ASO's short interest increased by 0.80% to 7.81 million shares, representing 13.13% of the public float, with a short interest ratio …
Cadeler signs $929m contract for T-class wind installation vessels
Cadeler has signed firm contracts worth approximately $929 million with COSCO Shipping Offshore shipyard for the construction of two new T-class offshore wind installation vessels. These vessels, expected to be delivered in 2030 and 2031, are designed to handle complex offshore wind projects with …
Cadeler Orders Two More WTIV Vessels Citing Continued Strong Sector Demand
Cadeler, a leader in offshore wind installation, has ordered two new "T-class" Wind Turbine Installation Vessels (WTIVs) from COSCO Shipping Offshore shipyard, valued at approximately €805 million (US$930 million). These vessels, scheduled for delivery in 2030 and 2031, will expand Cadeler's fleet to 14, …
Cadeler (OB:CADLR), Why Is It Drawing Fresh Attention?
Cadeler has secured two new offshore wind installation vessels through contracts with COSCO Shipping Offshore, set to join its fleet in 2030 and 2031, worth €805 million. Despite recent share price cooling with a 13.66% decline over 90 days, its 5-year total shareholder return …
Palisade Bio Q2 Net Loss Expands; Plans Phase 2 ASCENTRA-UC Trial Enrollment In H2 2026; Stock Down
(RTTNews) - Palisade Bio, Inc. (PALI), a clinical-stage biopharmaceutical company, reported financial results for the second quarter ended June 30, 2026, reflecting a wider net loss and provided a business update. Company Profile Palisade Bio develops prodrugs for patients living with inflammatory and fibrotic …
Adeia (ADEA) Q2 2026 Earnings Call Transcript
Image source: The Motley Fool. DATE Monday, Aug. 3, 2026 at 5 p.m. ET CALL PARTICIPANTS Vice President and Investor Relations - Chris ChaneyPresident and Chief Executive Officer - Paul DavisChief Financial Officer - Keith Jones TAKEAWAYS Revenue -- $96.1 million, driven by the …
Cadeler Orders Two T-Class Offshore Wind Vessels at COSCO SHIPPING (Qidong) Offshore
Cadeler has signed a contract with COSCO SHIPPING (Qidong) Offshore for the construction of two new T-class offshore wind turbine installation vessels, valued at approximately EUR 805 million. These vessels are expected to be delivered in 2030 and 2031 and are designed to be …
Jade Biosciences, Inc. Stock 12‑Month Price Target Raised to $46.44, Implies 111% Upside
Analysts have raised the average 12-month price target for Jade Biosciences, Inc. (JBIO) stock from $45.89 to $46.44, with individual forecasts ranging from $25 to $77 per share. This new target suggests a potential upside of approximately 111% from the Aug. 7 closing price. …
Cadeler Orders Two New T-Class Wind Installation Vessels for 2030-2031 Delivery - News and Statistics
Cadeler has ordered two new T-class offshore wind installation vessels from COSCO Shipping Offshore shipyard, valued at approximately EUR805 million (US$930 million), with deliveries expected in 2030 and 2031. These vessels are designed to be the largest and most capable in the industry, enhancing …
Why The Trade Desk (TTD) Shares Are Plunging Today
Why The Trade Desk (TTD) Shares Are Plunging Today What Happened? Shares of digital advertising platform The Trade Desk (NASDAQ:TTD) fell 21.1% in the afternoon session after the company reported a weak second-quarter earnings report and a third-quarter outlook. The company reported Q2 2026 …
Sharemaestro market context Price below Trend Line 52 weeks -75.7% · Next-week setup negative 41.3%Palisade Bio plans phase 2 ulcerative colitis trial in 2H 2026
Palisade Bio (NASDAQ:PALI) announced plans to initiate a Phase 2 clinical trial for its drug candidate PALI-2108 in ulcerative colitis during the second half of 2026, with results expected in late 2027. The company also intends to file an investigational new drug application for …
Palisade Bio (NASDAQ:PALI) Releases Quarterly Earnings Results, Hits Expectations
Palisade Bio (NASDAQ:PALI) announced its quarterly earnings, reporting a loss of $0.05 per share, which met analyst expectations, and revenue of $0.50 million. The stock saw a slight dip, trading down 0.5% to $2.10, while analysts maintain an overall "Buy" rating with a target …
Palisade Bio Q2 Results: Net loss widens to $10.6 million on R&D surge
Palisade Bio (NASDAQ: PALI) reported a Q2 2026 net loss of $10.6 million, significantly wider than the $2.8 million loss in Q2 2025, primarily due to increased R&D expenses for its lead candidate, PALI-2108. Despite the widening loss, the company's EPS of $(0.05) met …
Cadence Design Systems Inc. stock underperforms Monday when compared to competitors
Cadence Design Systems Inc. (CDNS) stock fell 2.16% on Monday, underperforming the broader market. This drop occurred despite the S&P 500 Index and Dow Jones Industrial Average experiencing only slight declines. The stock's fall ended a two-day winning streak.
PALISADE BIO, INC. Q2 2026: Revenue $0.5M, EPS $(0.05) — 10-Q Summary
PALISADE BIO, INC. (PALI) reported second-quarter 2026 financial results with $0.5 million in revenue and a net loss of $10.6 million, or $(0.05) diluted EPS. This marks an increase in revenue compared to the year-ago quarter, though the net loss widened. The company also …
Palisade Bio expects once-daily drug trial for bowel disease to start in 2H
Palisade Bio reported Q2 2026 financial results, including a net loss of $10.6 million, and provided an update on its lead Inflammatory Bowel Disease (IBD) candidate, PALI-2108. The company plans to initiate Phase 2 ASCENTRA-UC trials for ulcerative colitis in the second half of …
Academy Sports partners with Instacart for same-day delivery in as fast as one hour
Academy Sports & Outdoors has partnered with Instacart to provide same-day delivery services, with orders fulfilled in as fast as one hour. This collaboration expands Academy's omnichannel reach to over 300 stores across 21 states, allowing customers to access their full product assortment through …